Skip to main content
. 2021 Apr 2;22(7):3714. doi: 10.3390/ijms22073714

Figure 8.

Figure 8

Principal component analysis (F1 versus F2) applied to the molecular descriptor matrix of the selected compounds merged with the known Cdc25 inhibitors.